Cited by 229Renal Transplantation Outcomes and TreatmentsViral-associated cancers and disordersRenal cell carcinoma treatment

The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.

Malignancy in Renal Transplantation

Morath, Christian, Mueller, Martina, Goldschmidt, Hartmut, Schwenger, Vedat, Opelz, Gerhard, Zeier, Martin·2004·Journal of the American Society of Nephrology

DOI 10.1097/01.asn.0000126194.77004.9b

Open this paper in CoChat — free account

Abstract

Eberhard Ritz : Feature Editor An increased incidence of malignant tumors in transplant recipients was recognized as early as in the 1970s, and this effect was ascribed to the administration of immunosuppressive medication ([1,2][1][⇓][2]). In the early days of transplantation medicine, however

Integrity signals

Registry

Crossref · 10.1097/01.asn.0000126194.77004.9b

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
Guba, M. O., von Breitenbuch, P., Steinbauer, M. G. M., Koehl, G. E., Flegel, S., Hornung, M., Bruns, C. J., Zuelke, C., Farkas, S. A., Anthuber, M., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-128 · Cited by 1,739
Progress in human tumour immunology and immunotherapy
Rosenberg, S. A. (2001) · Nature · doi:10.1038/35077246 · Cited by 1,317
A Follow-up Study
Zacks, C. M., Abbott, R. L., & Fine, M. (1990) · Cornea · doi:10.1097/00003226-199004000-00002 · Cited by 1,240
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
Müller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S. L., Galle, P. R., Stremmel, W., Oren, M., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2033 · Cited by 878
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study
Maisonneuve, P., Agodoa, L. Y. C., Gellert, R., Stewart, J. H., Buccianti, G., Lowenfels, A. B., Wolf, R. A., Jones, E., Dsiney, A. P., Briggs, D., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)06154-1 · Cited by 875
The Role of c-FLIP in Modulation of CD95-induced Apoptosis
Scaffidi, C., Schmitz, I., Krammer, P. H., & Peter, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1541 · Cited by 819
Long-term survival in renal transplant recipients with graft function
OJO, A. O., Hanson, J. A., Wolfe, R. A., Leichtman, A. B., Agodoa, L. Y. C., & Port, F. K. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00816.x · Cited by 810
Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management
Berg, D., & Otley, C. C. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.125579 · Cited by 723
Cancer epidemiology in the last century and the next decade
Peto, J. (2001) · Nature · doi:10.1038/35077256 · Cited by 688
Incidence of non-hodgkin lymphoma in kidney and heart transplant recipients
Opelz, G., & Henderson, R. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80084-4 · Cited by 656
Self-citation
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
Kasiske, B. L., Vazquez, M. A., Harmon, W., Brown, R. S., Danovitch, G. M., Gaston, R. S., Roth, D., Scandling, J. D., & Singer, G. G. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11suppl_1s1 · Cited by 627
Cancer risk after renal transplantation in the nordic countries, 1964–1986
Birkeland, S. A., Storm, H. H., Lamm, L. U., Barlow, L., Blohmé, I., Forsberg, B., Eklund, B. H., Fjeldborg, O. C., FRIEDBERG, M., Frödin, L., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600209 · Cited by 614
Testing for Polyomavirus Type BK DNA in Plasma to Identify Renal-Allograft Recipients with Viral Nephropathy
Nickeleit, V., Klimkait, T., Binet, I., Dalquen, P., Zenero, V. D., Thiel, G. T., Mihatsch, M. J., & Hirsch, H. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421802 · Cited by 500
THE RISK OF SKIN CANCER IN RENAL TRANSPLANT RECIPIENTS IN QUEENSLAND, AUSTRALIA
Bavinck, J. N. B., Hardie, D. R., Green, A. C., Cutmore, S., MacNaught, A., O’Sullivan, B., Siskind, V., van der Woude, F. J., & Hardie, I. R. (1996) · Transplantation · doi:10.1097/00007890-199603150-00008 · Cited by 492
Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals
Harwood, C. A., Surentheran, T., McGregor, J., Spink, P. J., Leigh, I. M., Breuer, J., & Proby, C. M. (2000) · Journal of Medical Virology · doi:10.1002/1096-9071(200007)61:3 · Cited by 420
Post-Transplant Malignancy
Penn, I. (2000) · Drug Safety · doi:10.2165/00002018-200023020-00002 · Cited by 416
Risk of neoplasia in renal transplant patients
London, N. J. M., Farmery, S. M., Lodge, J. P. A., Will, E. J., & Davidson, A. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92780-8 · Cited by 394
PREVENTION AND TREATMENT
CLEMENT, M., & Sekulich, M. (1944) · Elsevier eBooks · doi:10.1016/b978-1-4831-8000-7.50006-7 · Cited by 390
European Best Practice Guidelines for Renal Transplantation (Part 2).
Berthoux, F. C., Abramowicz, D., Ekberg, H., Frei, U. A., Morales, J., Ølgaard, K., Paul, L., & Pontecelli, C. (2002) · Lund University Publications (Lund University) · Cited by 371
THE EFFECT OF IMMUNOSUPPRESSION ON PRE-EXISTING CANCERS
Penn, I. (1993) · Transplantation · doi:10.1097/00007890-199304000-00011 · Cited by 343
Anti–B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ Transplantation
Fischer, A., Blanche, S., Bidois, J. L., Bordigoni, P., Garnier, J. L., Niaudet, P., Morinet, F., Deist, F. L., Fischer, A., Griscelli, C., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105233242102 · Cited by 342
Causes of death after renal transplantation
Briggs, J. D. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.8.1545 · Cited by 340
Cancer risk in patients on dialysis and after renal transplantation
Birkeland, S. A., L�kkegaard, H., & Storm, H. H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02298-4 · Cited by 296
An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab
Boye, J., Elter, T., & Engert, A. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg175 · Cited by 294
A time to kill: viral manipulation of the cell death program
Hay, S., & Kannourakis, G. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-7-1547 · Cited by 293
Assignment 1 of the human PHLDA1 gene to chromosome 12q15 by radiation hybrid mapping
Kuske, M., & Johnson, J. P. (2000) · Cytogenetic and Genome Research · doi:10.1159/000015575 · Cited by 288
Cancers in Renal Transplant Recipients
Penn, I. (2000) · Advances in Renal Replacement Therapy · doi:10.1053/rr.2000.5269 · Cited by 286
SECTION IV: Long-term management of the transplant recipient
(2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_4.3 · Cited by 243
Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein–Barr virus-induced B-cell lines
Bird, A. G., McLachlan, S. M., & Britton, S. (1981) · Nature · doi:10.1038/289300a0 · Cited by 242
Transplant tumor registry: donor related malignancies
Kauffman, H. M., McBride, M., Cherikh, W. S., Spain, P., Marks, W. H., & Roza, A. M. (2002) · Transplantation · doi:10.1097/00007890-200208150-00011 · Cited by 242
Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients
Ramsay, H. M., Fryer, A. A., Reece, S. M., Smith, A. G., & Harden, P. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.8290 · Cited by 233
Patient survival after renal transplantation; more than 25 years follow-up
Arent, S., Mallat, M. J. K., Westendorp, R., van der Woude, F., & van Es, L. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.8.1672 · Cited by 231
Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis
Brodt, P., Fallavollita, L., Bresalier, R. S., Meterissian, S. H., Norton, C. R., & Wolitzky, B. A. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970516)71:4 · Cited by 225
Incidence and treatment of neoplasia after transplantation.
Penn, I. (1994) · PubMed · Cited by 207
Evaluation of transplant candidates with pre-existing malignancies.
Penn, I. (1997) · PubMed · Cited by 200
Viruses and apoptosis
Thomson, B. J. (2001) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2001.iep195.x · Cited by 190
Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunity.
Seaman, W. E., Sleisenger, M. H., Eriksson, E., & Koo, G. C. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.12.4539 · Cited by 187
Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: Frequency of Epstein-Barr virus and other features associated with immunosuppression
Kamel, O. W., van de Rijn, M., LeBrun, D. P., Weiss, L. M., Warnke, R. A., & Dorfman, R. F. (1994) · Human Pathology · doi:10.1016/0046-8177(94)90295-x · Cited by 184
The cardiotoxicity of adriamycin and daunomycin in children
Gilladoga, A. C., Manuel, C., TAN, C. T. C., Wollner, N., Sternberg, S. S., & Murphy, M. L. (1976) · Cancer · doi:10.1002/1097-0142(197602)37:2+ · Cited by 171
RISK FACTORS FOR CANCER IN RENAL TRANSPLANT RECIPIENTS1
Danpanich, E., & Kasiske, B. L. (1999) · Transplantation · doi:10.1097/00007890-199912270-00008 · Cited by 127
Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: Two cases of after solid organ transplantation
Pirsch, J. D., Stratta, R. J., Sollinger, H. W., Hafez, G. R., D'Allesandro, A. M., Kalayoğlu, M., & Belzer, F. O. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90279-9 · Cited by 123
Skin cancer in heart transplant recipients: frequency and risk factor analysis
Fortina, A. B., Caforio, A. L. P., Piaserico, S., Alaibac, M., Tona, F., Feltrin, G., Livi, U., & Peserico, A. (2000) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(99)00137-0 · Cited by 116
Biology and clinical impact of human natural killer cells
Farag, S. S., VanDeusen, J. B., Fehniger, T. A., & Caligiuri, M. A. (2003) · International Journal of Hematology · doi:10.1007/bf02983234 · Cited by 109
Malignancy after renal transplantation
Zeier, M. G., Hartschuh, W., Wiesel, M., Lehnert, T., & Ritz, E. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.29926 · Cited by 104
Self-citation
Quantification of personal solar UV exposure of outdoor workers, indoor workers and adolescents at two locations in Southeast Queensland
Kimlin, M. G., Parisi, A. V., & Wong, J. C. F. (1998) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/j.1600-0781.1998.tb00002.x · Cited by 97
Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study
Pommer, W., Bronder, E., Klimpel, A., Helmert, U., Greiser, E. M., & Molzahn, M. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.12.2892 · Cited by 92
Cell transformation by the middle T-antigen of polyoma virus
Ichaso, N., & Dilworth, S. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204859 · Cited by 92
Development and incidence of cancer following cyclosporine therapy.
Penn, I. M., & First, M. R. (1986) · PubMed · Cited by 89
The incidence of cancer associated with the treatmentof rheumatoid arthritis
Beauparlant, P., Papp, K. A., & Haraoui, B. P. (1999) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(99)80026-2 · Cited by 88
The compliance of renal transplant recipients with advice about sun protection measures
Seukeran, Newstead, & Cunliffe (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02079.x · Cited by 87
RESULTS OF RENAL TRANSPLANTATION IN PATIENTS WITH RENAL CELL CARCINOMA AND VON HIPPEL-LINDAU DISEASE1,2
Goldfarb, D. A., Neumann, H. P. H., Penn, I., & Novick, A. C. (1997) · Transplantation · doi:10.1097/00007890-199712270-00017 · Cited by 79
Kaposi's sarcoma in renal transplant recipients.
Mh, A.-S., & Aa, A.-K. (1994) · PubMed · Cited by 79
Risk of renal cell carcinoma after kidney transplantation
Kliem, V., Kolditz, M., Behrend, M., Ehlerding, G., Pichlmayr, R., Koch, K. M., & Brunkhorst, R. (1997) · Clinical Transplantation · doi:10.1111/j.1399-0012.1997.tb00815.x · Cited by 75
Skin cancers after transplantation
Dréno, B. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg023 · Cited by 73
Posttransplant lymphoproliferative disorder associated with an epstein-barr-related virus in cynomolgus monkeys1
Schmidtko, J., Wang, R., Wu, C., Mauiyyedi, S., Harris, N. L., Pelle, P. D., Brousaides, N. L., Zagachin, L. M., Ferry, J. A., Wang, F., et al. (2002) · Transplantation · doi:10.1097/00007890-200205150-00012 · Cited by 67
Malignant Tumours in Renal Transplant Recipients Receiving Cyclosporin: Survey of 598 First-Kidney Transplantations
Vogt, P., Frei, U. A., Repp, H., Bunzendahl, H., Oldhafer, K. J., & Pichlmayr, R. (1990) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/5.4.282 · Cited by 66
Polyoma Virus: Old Findings and New Challenges
Benjamin, T. L. (2001) · Virology · doi:10.1006/viro.2001.1124 · Cited by 62
Hepatitis C virus infection in patients with chronic liver disease or chronic renal failure and blood donors in Thailand
Luengrojanakul, P., Vareesangthip, K., Chainuvati, T., Murata, K., Tsuda, F., Tokita, H., Okamoto, H., Miyakawa, Y., & Mayumi, M. (1994) · Journal of Medical Virology · doi:10.1002/jmv.1890440313 · Cited by 59
Early Events of Hepatic Metastasis Formation in Mice: Role of Kupffer and NK-Cells in Natural and Interferon-γ-Stimulated Defense
Rushfeldt, C. F., Sveinbjørnsson, B., Seljelid, R., & Smedsrød, B. H. (1999) · Journal of Surgical Research · doi:10.1006/jsre.1998.5532 · Cited by 59
Malignancies in rheumatoid arthritis patients treated with cyclosporin A.
Arellano, F., & Krupp, P. F. (1993) · PubMed · Cited by 59
Epidermal dysplasia and cyclosporine therapy in renal transplant patients: a comparison with azathioprine
Shuttleworth, D., Marks, R., Griffin, P., & Salaman, J. R. (1989) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1989.tb01330.x · Cited by 51
TRANSPLANTATION-ASSOCIATED MALIGNANCIES
Cathomas, G., Tamm, M., McGandy, C. E., Itin, P. H., Gudat, F. G., Thiel, G. T., & Mihatsch, M. J. (1997) · Transplantation · doi:10.1097/00007890-199707150-00033 · Cited by 50
Malignancy following renal transplantation.
Sheil, A. G. R., Disney, A. P. S., Mathew, T. G., Amiss, N., & Excell, L. (1992) · PubMed · Cited by 49
Immunomodulatory Effects of Anti-CD4 Antibody in Host Resistance against Infections and Tumors in Human CD4 Transgenic Mice
Herzyk, D. J., Gore, E. R., Polsky, R., Nadwodny, K. L., Maier, C. C., Liu, S., Hart, T. K., Harmsen, A. G., & Bugelski, P. J. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.1032-1043.2001 · Cited by 47
TREATMENT OF CENTRAL NERVOUS SYSTEM B LYMPHOPROLIFERATIVE SYNDROME BY LOCAL INFUSION OF A B CELL-SPECIFIC MONOCLONAL ANTIBODY
Stéphan, J.-L., Deist, F. L., Blanche, S., Bidois, J. L., Peuchmaur, M. M., Lellouch‐Tubiana, A., Hirn, M. H., Griscelli, C., & Fischer, A. (1992) · Transplantation · doi:10.1097/00007890-199208000-00011 · Cited by 40
Catheter introduction in perineal urethrostomies
Tolhurst, D. E. (1977) · Urology · doi:10.1016/0090-4295(77)90043-7 · Cited by 37
Cyclophosphamide-induced bladder cancer.
Vlaovic, P. D., & Jewett, M. A. S. (1999) · PubMed · Cited by 36
Post-transplant Kaposi's sarcoma.
Gotti, E., & Remuzzi, G. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v81130 · Cited by 35
Misdiagnosed malignancy in transplanted organs
Detry, O., Detroz, B., D’Silva, M., Pirenne, J., Defraigne, J.-O., Meurisse, M., Honor�, P., Michel, P., Boniver, J., Limet, R., et al. (1993) · Transplant International · doi:10.1007/bf00336641 · Cited by 35
Malignancy following renal transplantation.
Yang, T., Shu, K.-H., Cheng, C. H., Wu, M. J., & Lian, J.-D. (1998) · PubMed · Cited by 31
Adjuvant immunotherapy for melanoma and colorectal cancers
Safa, M. M., & Foon, K. A. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90046-6 · Cited by 24
Fatal outcome of renal transplantation in a patient with the Wiskott-Aldrich syndrome
Fischer, A., Binet, I., Oertli, D., Böck, A., & Thiel, G. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/oxfordjournals.ndt.a027102 · Cited by 21
Successful treatment of Epstein-Barr virus-associated T-Cell cutaneous lymphoma in a renal allograft recipient: case report and review of the literature
Wc, L. (2000) · Transplantation Proceedings · doi:10.1016/s0041-1345(00)01524-4 · Cited by 19
Novel immunologic approaches to the management of malignant melanoma
Weber, J. S., & Aparicio, A. M. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200103000-00007 · Cited by 16
Carcinoma of the Bladder in a Renal Transplant Patient
Biggs, A. W. (1973) · The Journal of Urology · doi:10.1016/s0022-5347(17)60439-7 · Cited by 15
TESTING FOR POLYOMAVIRUS TYPE BK DNA IN PLASMA TO IDENTIFY RENAL-ALLOGRAFT RECIPIENTS WITH VIRAL NEPHROPATHY
Ickeleit, V. O. N., Limkait, T. H. K., Inet, I. S. F. B., Eter, P., El, V., Enero, Z., Hiel, G. I. T., Ichael, M., Ihatsch, J. M., & Irsch, H. A. H. H. (2000) · Cited by 14
Unexpected Wilms’ tumor in a pediatric renal transplant recipient: suspected Denys-Drash syndrome
Cleper, R., Davidovitz, M., Krause, I., Bar-Nathan, N., Ash, S., Schwarz, M., Mor, C., & Eisenstein, B. (1999) · Transplantation Proceedings · doi:10.1016/s0041-1345(99)00150-5 · Cited by 11
Multiple solid malignancies in a renal transplant patient
Gomez, E., Portal, C., Seco, M., & Alvarez-Grande, J. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.3.803 · Cited by 11
Colonoscopy Findings in Renal Transplant Patients With Abdominal Symptoms
Baysal, Ç., Gür, G., Gürsoy, M., Üstündağ, Y., Demirhan, B., Boyacıoğlu, S., & Bi̇lgi̇n, N. (1998) · Transplantation Proceedings · doi:10.1016/s0041-1345(98)00034-7 · Cited by 7
Tumoral calcinosis after an injection of recombinant human erythropoietin in a dialysis patient
Wong, P.-N., Mak, S., Lo, K., Tong, G. M. W., Gwi, E., & Wong, A. K. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.34549 · Cited by 6

Sorted by citations

Evolution of the immune system in humans from infancy to old age
Simon, A. K., Hollander, G. A., & McMichael, A. (2015) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2014.3085 · Cited by 1,796
Cancer immunoediting from immune surveillance to immune escape
Kim, R., Emi, M., & Tanabe, K. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02587.x · Cited by 1,145
Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients
Stallone, G., Schena, A., Infante, B., Paolo, S. D., Loverre, A., Maggio, G., Ranieri, E., Gesualdo, L., Schena, F. P., & Grandaliano, G. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042831 · Cited by 982
Lower Malignancy Rates in Renal Allograft Recipients Converted to Sirolimus-Based, Calcineurin Inhibitor-Free Immunotherapy: 24-Month Results From the CONVERT Trial
Alberú, J., Pascoe, M. D., Campistol, J. M., Schena, F. P., Rial, M. D. C., Polinsky, M. S., Neylan, J. F., Korth-Bradley, J. M., Goldberg-Alberts, R., & Maller, E. S. (2011) · Transplantation · doi:10.1097/tp.0b013e3182247ae2 · Cited by 224
Malignancy after renal transplantation: the role of immunosuppression
Rama, I., & Grinyo, J. M. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.102 · Cited by 193

See all 229

Authors: Morath, C., Mueller, M., Goldschmidt, H., Schwenger, V., Opelz, G., & Zeier, M.
Affiliations: Heidelberg University (DE)
ORCID: Morath, Christian
Mueller, Martina
Goldschmidt, Hartmut
Schwenger, Vedat
Zeier, Martin
Venue: Journal of the American Society of Nephrology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2004-06
Volume: 15
Issue: 6
Pages: 1582-1588
ISSN: 1046-6673 (ISSN-L)
DOI: 10.1097/01.asn.0000126194.77004.9b
OpenAlex: W2142862239
Cited by: 229
References: 81
Citations by year: 2026: 1 · 2025: 5 · 2024: 2 · 2023: 5 · 2022: 12 · 2021: 9 · 2020: 9 · 2019: 9 · 2018: 13 · 2017: 10 · 2016: 9 · 2015: 14 · 2014: 10 · 2013: 9 · 2012: 17
FWCI: 9.06
Type: journal article
Language: en
Open access: closed
Locations: Journal of the American Society of Nephrology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
Keywords: kidney transplantation, cancer, immunosuppressive therapy
MeSH terms: Humans, Immunosuppressive Agents, Kidney Neoplasms, Postoperative Complications, Virus Diseases, Kidney Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Malignancy in Renal Transplantation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks